Skip to main content

Value messaging in breast cancer

Our medical writers have produced a compelling value message for a treatment in metastatic breast cancer.

What we did

Project background

A client was working on a novel intervention in oncology. The intervention produced by the client had demonstrated superior efficacy and tolerable safety in phase III clinical trial in a new indication, and the client required strong value messaging as part of a global value dossier to support their application for market access in this indication.

Challenges faced

Value communication for the global value dossier needed to reflect the messaging for the clinical trial outcomes in terms of efficacy and safety benefit, the messaging for the intervention's impact on the unmet need and quality of life of patients, and the health and economic value presented in the dossier itself. A coherent and compelling value message for the new indication had to incorporate these viewpoints and align with multiple documents.

Our solution

 Health and economic data from the global value dossier was reframed into clear and effective value messages in a series of key areas, including the burden of disease, therapeutic landscape, unmet need, therapeutic value, and economic value, among others. The tone, style, and substance of these messages were aligned with the existing value documents for clinical trial outcomes and quality of life outcomes (i.e., patient-reported outcomes) to ensure a cohesive overview of the value and significance of the intervention for payers and patients.

Our impact

We had multiple review rounds with the client to arrive at a format that satisfied all project needs and the client's wishes:  comprehensive summary messages highlighting the key value of the intervention for a particular area were supported and substantiated by messages emphasizing the constituent value elements.  With client approval secured, the project was deemed successful, and the global value dossier has since been used to support (ongoing) market access submissions

Do you have a question? just asc